Annexon, Inc. (ANNX)
Market: NASD |
Currency: USD
Address: 1400 Sierra Point Parkway
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Show more
📈 Annexon, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$11.60
-
Upside/Downside from Analyst Target:
395.73%
-
Broker Call:
16
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
10-25%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Annexon, Inc.
| Date | Reported EPS |
|---|
| 2026-03-02 (estimated upcoming) | - |
| 2025-11-12 (estimated upcoming) | - |
| 2025-11-11 (estimated upcoming) | - |
| 2025-08-11 (estimated upcoming) | - |
| 2025-08-10 (estimated upcoming) | - |
| 2025-05-12 | - |
| 2025-05-11 | - |
| 2025-03-23 | - |
| 2025-03-03 | -0.33 |
| 2024-11-14 | -0.25 |
| 2024-08-12 | -0.23 |
| 2024-08-11 | -0.23 |
| 2024-05-13 | -0.21 |
| 2024-05-12 | -0.21 |
| 2024-03-26 | -0.36 |
| 2024-03-25 | -0.36 |
| 2023-11-13 | -0.43 |
| 2023-11-12 | -0.43 |
| 2023-08-07 | -0.47 |
| 2023-08-06 | -0.47 |
| 2023-05-08 | -0.52 |
| 2023-05-07 | -0.52 |
| 2023-03-06 | -0.48 |
| 2023-03-05 | -0.48 |
| 2022-11-03 | -0.51 |
| 2022-11-02 | -0.51 |
| 2022-08-08 | -0.96 |
| 2022-08-07 | -0.96 |
| 2022-05-09 | -0.92 |
| 2022-05-08 | -0.92 |
| 2022-03-01 | -0.97 |
| 2022-02-28 | -0.97 |
| 2021-11-09 | -0.93 |
| 2021-11-08 | -0.93 |
| 2021-08-16 | -0.82 |
| 2021-08-15 | -0.82 |
| 2021-05-17 | -0.68 |
| 2021-05-16 | -0.68 |
| 2021-03-25 | -0.61 |
| 2021-03-24 | -0.61 |
| 2020-11-16 | -0.55 |
| 2020-11-15 | -0.55 |
| 2020-09-08 | -28.87 |
| 2020-09-07 | -28.87 |
| 2020-07-24 | - |
| 2020-07-23 | - |
📰 Related News & Research
No related articles found for "annexon inc".
